European Medicines Agency Reviewing Use of Epilim

The European Medicines Agency (EMA) is currently reviewing the use of Epilim to treat cases of Epilepsy following a number of report that have linked it to instances of birth defects and disability. Epilim, a drug which Epilepsy Ireland has urged doctors not to...

22% Increase in State Compensation Claims

A recent report by the State Claim Agency has revealed that there was an increase in the cost of compensation claims taken against the State, bringing the overall spend to approximately €2.2 billion during 2016. This is a 22% increase on the previous year’s...

Report Reveals Most Common Clinical Incidents in Ireland

The State Claims Agency has published a report revealing the most common clinical incidents in Ireland and the cost of settling clinical negligence claims. The report – National Clinical Incidents, Claims and Costs – covers the period between 2010 and...

Unprotected Chemical Exposure Claims against the Defence Forces

New unprotected chemical exposure claims against the Defence Forces, made by a former Baldonnel-based air corps mechanic, have been published in the Journal. Working conditions at the Casement Airbase in Baldonnel, County Dublin, have been the subject of investigation...

Claims for Birth Defects due to taking Epilim

Claims for birth defects due to taking Epilim while pregnant have been made in France on behalf of up to 4,100 children with foetal valproate syndrome. Epilim is the trade name of an anti-epilepsy drug that uses the active ingredient sodium valproate to control...